跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LINAGLIPTINA/METFORMINA STADA 2,5 MG/850 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
LINAGLIPTINA/METFORMINA STADA 2,5 MG/850 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Approved
STANDARD
LINAGLIPTINA/METFORMINA STADA 2,5 MG/850 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Laboratorio Stada S.L.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jul 4, 2024
Approval ID
e0904a637a2d9c91
Company
Laboratorio Stada S.L.
Type
Standard
Approval Details
Approval Id
e0904a637a2d9c91
Drug Cima Aemps Name
LINAGLIPTINA/METFORMINA STADA 2,5 MG/850 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number
89684
Holder Company Name
Laboratorio Stada S.L.
Marketing Company Name
Laboratorio Stada S.L.
Authorization Date
2024-07-04
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
2,5 mg/850 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Laboratorio Stada S.L.
Active Ingredients
LINAGLIPTINA
2,50 mg
METFORMINA HIDROCLORURO
850 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jul 4, 2024
Approval ID
e0904a637a2d9c91
Type
Standard
Back to CIMA-AEMPS Approvals